MedTrace Logo

Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheters

NCT06720064 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-12-06

No results posted yet for this study

Summary

In order to provide treatment in pediatric hematology-oncology patients, in some cases a central venous catheter is required in children. The most important situation to pay attention to when using a central venous catheter is "Central line-associated bloodstream infections".

These infections are infections that develop after admission to the hospital and are not in the incubation period at the time of admission, or although they usually develop in the hospital 48-72 hours after hospitalization, they can sometimes appear after discharge. Central line-associated bloodstream infections significantly increase morbidity and mortality. In this context, the effect of using a care bundle containing chlorhexidine dressing on port catheter and central venous catheter-related bloodstream infections in pediatric cancer patients was examined.

Conditions

  • Pediatric Cancer

Interventions

DEVICE

Chlorhexidine Dressing

Transparent catheter cover with Chlorhexidine (3M™ CHG Tegaderm™)

Sponsors & Collaborators

  • Afyonkarahisar Health Science University

    collaborator UNKNOWN

  • Dokuz Eylul University

    lead OTHER

Principal Investigators

  • Gulcin Ozalp Gerceker, Assoc. Prof. · Dokuz Eylul University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-07
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06720064 on ClinicalTrials.gov